IGC

IGC Pharma, Inc.

0.20

USD

+0.01

+5.82%

Nov 06, 15:59 UTC -5

Closed

After-Market

0.20

0.00

-1.00%

IGC Pharma, Inc. (IGC) Profile

IGC Pharma, Inc. Profile

About

IGC Pharma Inc. develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. IGC Pharma Inc., formerly known as India Globalization Capital Inc., is based in POTOMAC, Md.

Info & Links

CEO

Ram Mukunda

Headquarters

10224 FALLS ROAD
POTOMAC, MD 20854, UNITED STATES

Auditor

Manohar Chowdhry & Associates

Share holders

Employees

IGC Pharma, Inc. Statistics

Valuation Measures

Market Capitalization²

20.47M

Enterprise Value

21.22M

Enterprise Value/EBITDA(ttm)

-2.63

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

20.26

Price to Book(mrq)

3.15

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

21.82%

Operating Margin(ttm)

Profit Margin(ttm)

-704.76%

Return on Equity(ttm)

-99.21%

Return on Invested Capital(ttm)

-106.94%

Return on Assets(ttm)

-74.18%

Income Statement

Revenue(ttm)

773.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

202.00K

EBITDA(ttm)³

-8.06M

Net Income Available to Common(ttm)

-7.16M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

0.55

52-Week Change

-48.15%

S&P 500 52-Week Change

14.03%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

103.38M

Dividend Yield

0.00%

Float⁴

88.66M

% Held by Insiders

23.66%

% Held by Institutions

3.87%

Balance Sheet

Total Cash(mrq)

354.00K

Total Cash Per Share(mrq)

0.00

Total Debt(mrq)

1.08M

Total Debt/Equity(mrq)

17.65%

Current Ratio(mrq)

0.39%

Quick Ratio(mrq)

0.19%

Book Value Per Share(mrq)

0.06

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.03

Free Cash Flow(ytd)

-2.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.